logologo
QuantliQuantli

Neurogene Inc

NGNE

NASDAQ

Biotechnology

$36.14

USD

+0.51 (+1.43%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $719.91M

Volume 115.9K

Price Target

$65.00$81.00

USD

The 2 analysts offering 1-year price forecasts have a max estimate of $81.00 and a min estimate of $65.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$73.00

-$107.0 vs prior

Implied Upside

+102.0%

-296.1% vs prior

Analyst Covering

2

+1 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

67%

Most ratings are recent - from the last 3 months

Analyst Agreement

Moderate

Targets show moderate spread across analysts

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

2 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

2 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Mitchell S. Kapoor

HC Wainwright & Co.

Buy

Maintained

3 days ago

Plus
Plus
Plus

Debjit Chattopadhyay

Guggenheim

Buy

Maintained

3 days ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

GYRE

Gyre Therapeutics Inc

$6.68

+2.1%

MNPR

Monopar Therapeutics Inc

$113.04

+2.4%

BBOT

BridgeBio Oncology Therapeutics Inc

$9.06

-1.8%

CTMX

CytomX Therapeutics Inc

$3.36

+0.3%

RGNX

Regenxbio Inc

$10.77

+1.0%

ALLO

Allogene Therapeutics Inc

$2.05

+3.5%

TECX

Tectonic Therapeutic Inc

$34.91

+2.7%

IRWD

Ironwood Pharmaceuticals Inc

$4.31

+5.6%